Full paper/MémoireSqualene versus cholesterol: Which is the best nanocarrier for the delivery to cells of the anticancer drug gemcitabine?Squalène ou cholestérol : quel est le meilleur nanovecteur pour la délivrance de l'anticancéreux gemcitabine aux cellules ?

Add time:08/29/2019    Source:sciencedirect.com

It has been previously shown that the linkage of the anticancer drug gemcitabine (Gem) to the squalene (SQ), a natural lipid precursor of the cholesterol biosynthesis, allowed the resulting bioconjugates to spontaneously self-assemble as nanoparticles (NPs) with improved pharmacological activity. We show here that when the squalene moiety was replaced by the cholesterol and the conjugation performed through a carbamate linker, although rather stable nanoparticles were obtained, the in vitro anticancer activity in the human breast cancer cell line MDA-MB-231 was completely abolished. This was attributed to reduced enzymatic accessibility toward the carbamate linker, which may hamper the gemcitabine release. A lower propensity of incorporation into the plasma cell membrane, which was revealed by molecular simulations, may also play a role in lower activity of cholesterol derivative.

We also recommend Trading Suppliers and Manufacturers of CHOLESTEROL METHYL CARBONATE (cas 15507-52-5). Pls Click Website Link as below: cas 15507-52-5 suppliers

Prev:Cholesterol imprinted composite membranes for selective cholesterol recognition from intestinal mimicking solution
Next:Comparison of different cyclic organic carbonates in the oxyalkylation of various types of lignin)